MSB 1.03% $1.47 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-565

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,979 Posts.
    lightbulb Created with Sketch. 1537
    so one action is not dependent on the other. Two separate pathways forward... one a certainty IMO; and the other, Covid-ards, is still highly probable IMO.... backed up with no expertise.

    ummmm me think Novartis likes what they see.... as in really likes! smile.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.